Supernus Pharmaceuticals Acquires Biscayne NeuroTherapeutics
Supernus Pharmaceuticals acquired Biscayne NeuroTherapeutics for $185.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Supernus Pharmaceuticals
- Acquired Company
- Biscayne NeuroTherapeutics
- Price
- $185.0M
- Acquisition Type
- Acquisition
- Announced
- September 14, 2018
Canonical: https://fsome.com/acquisitions/supernus-pharmaceuticals-acquires-biscayne-neurotherapeutics-8215381 · For the full deal terms, timeline, and press references, please enable JavaScript.